| RS1368248226 |
LORICRIN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1368275632 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1368294758 |
ODAD3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 30, Primary ciliary dyskinesia 30 |
| RS1368296717 |
CASP8
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1368307429 |
ACY1
|
Health Risk |
Likely pathogenic |
Aminoacylase 1 deficiency, Aminoacylase 1 deficiency |
| RS1368316485 |
SLC38A3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 102, Developmental and epileptic encephalopathy 102 |
| RS1368322558 |
ESCO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Juberg-Hayward syndrome, Roberts-SC phocomelia syndrome |
| RS1368374192 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group C |
| RS1368387219 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS1368408 |
SCGB3A2
|
Health Risk |
risk factor |
Inherited susceptibility to asthma, Inherited susceptibility to asthma |
| RS1368412801 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1368414810 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1368439403 |
KCNH2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1368444664 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1368453406 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1368457771 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1368457816 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1368473544 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1368494641 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1368497638 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1368507241 |
DES
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Desmin-related myofibrillar myopathy |
| RS1368508052 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Retinitis pigmentosa |
| RS1368527802 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1368543726 |
ANO10
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS1368565489 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1368571528 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, ABCA4-related disorder |
| RS1368572 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS1368576380 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1368584894 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1368588434 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1368616115 |
GHRHR
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, Pituitary hormone deficiency |
| RS1368625580 |
PKD1L1
|
Health Risk |
Pathogenic |
— |
| RS1368647604 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1368661753 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1368668141 |
PKD1L1
|
Health Risk |
Likely pathogenic |
Situs inversus, Situs inversus |
| RS1368682729 |
PAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Otofaciocervical syndrome 2, Otofaciocervical syndrome 2 |
| RS1368720035 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1368727960 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome |
| RS1368733646 |
BBS10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 10 |
| RS1368733883 |
GUCY1A1
|
Health Risk |
Pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS1368752573 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1368757896 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1368764108 |
CCDC22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1368779496 |
DNMT3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS1368780488 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1368784894 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1368796043 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1368806849 |
CYP4F22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1368860049 |
PNP
|
Health Risk |
Likely pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS1368861313 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1368882599 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS1368897658 |
PRDX3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 32 |
| RS1368909419 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1368916345 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1368926188 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Ovarian cancer |
| RS1368938675 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1368969207 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1368983693 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, CHARGE syndrome |
| RS1368997812 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1369012080 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1369020144 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1369023278 |
CDH23
|
Health Risk |
Likely pathogenic |
CDH23-related disorder, CDH23-related disorder |
| RS1369026474 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1369028200 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1369055141 |
HLA-B
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1369065305 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1369076411 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS1369097739 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1369099437 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS1369118661 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1369125082 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1369125529 |
IL7R
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency disease, Immunodeficiency 104 |
| RS1369134650 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1369163428 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1369175943 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1369181601 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1369201943 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1369220541 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1369239753 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1369253342 |
KNG1
|
Health Risk |
Pathogenic |
Angioedema, hereditary |
| RS1369256964 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1369305726 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Perrault syndrome 1, Bifunctional peroxisomal enzyme deficiency |
| RS1369308468 |
AP3B2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1369313123 |
BBS9
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS1369327940 |
ASAH1
|
Health Risk |
Pathogenic |
— |
| RS1369349270 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1369360268 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome 2, Martsolf syndrome |
| RS1369374541 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1369399401 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1369404945 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, SCN1A-related disorder |
| RS1369414978 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS1369420640 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS1369425792 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1369428503 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS1369428850 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1369440486 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS1369454759 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis |
| RS1369460201 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1369462778 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1369466541 |
PHIP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |